The company is advancing next-generation oral and injectable treatments and raised $411M in an oversubscribed Series A round, co-led by Forbion and General Atlantic, with participation from RA Capital Management, OrbiMed, Logos Capital, Lilly Asia Ventures, and LYFE Capital
10.1007/s10142-010-0207-y Funct
The observed reduction in both systolic and diastolic left ventricular diameters, along with improved left ventricular ejection fraction in the LC supplemented group, suggests a potential contribution of CABG to reverse remodeling
Weekly Schedule (Example Week) The grid below shows one example week in each of the three phases
Get step-by-step protocols for reconstitution, injection technique, and dosing specific to your condition